IL-4 and -13 are related cytokines, encoded by closely linked genes ( 1 ) . IL-4 can signal through either the type I (IL-4R ␣ / ␥ c) or the type II (IL-4R ␣ /-13R ␣ 1) IL-4 receptor, whereas IL-13 signals exclusively via the type II IL-4 receptor ( 2 ) . IL-4 binds to IL-4R ␣ with high affi nity, triggering receptor heterodimerization either with ␥ c or with IL-13R ␣ 1. Downstream intracellular signaling from the IL-4 -IL-4R ␣ -␥ c complex involves activation of the Jak1 and Jak3 kinases, phosphorylation of the Stat6 transcription factor, and activation of the insulin receptor substrate (IRS)-2 -and Dok2-signaling intermediates ( 3 ). IL-13 initially binds to IL-13R ␣ 1 with intermediate affi nity, and then heterodimerizes with IL-4R ␣ . The IL-13 -IL-13R ␣ 1 -IL-4R ␣ complex activates the Tyk2, Jak2, and Jak1 kinases and Stat6 ( 2, 4, 5 ) . IL-13 can also bind with high affi nity to IL-13R ␣ 2, which is generally regarded to act as a decoy receptor, inhibiting IL-13 binding to IL-13R ␣ 1, and thus the formation of the functional type II receptor complex ( 6 ) , although it has been reported that the IL-13R ␣ 2 can transduce signals under certain conditions ( 7 ) . Because ␥ c expression is mainly restricted to hematopoietic cells, in nonhematopoietic cells both IL-4 and -13 are believed to use the type II receptor exclusively. However, it was recently discovered that fi broblasts from IL-13R ␣ 1 Ϫ / Ϫ mice are responsive to IL-4; these cells expressed ␥ c mRNA, suggesting that low levels of type I IL-4 receptor may be expressed in some types of fi broblasts ( 8 ) .
Despite the many similarities of IL-4 and -13, their principal functions are quite diff erent. In the mouse, priming for Th2 diff erentiation and immunoglobulin class switching are exclusive properties of IL-4, presumably because mouse T and B cells, lacking IL-13R ␣ 1, express type I but not type II receptors. In contrast, many eff ector functions, including airway hypersensitivity and mucus metaplasia in response to challenge with an antigen to which T cells have been sensitized, can be blocked by anti -IL-13, but not by anti -IL-4 ( 9 -11 ), indicating that IL-13 is the dominant eff ector cytokine. possibly analogous to monocytes. To study IL-4 -and IL-13 -induced responses in BMDMs, we chose to investigate the activation of Stat6, a key transcription factor activated by these cytokines. An indispensable event in Stat6 activation upon cytokine stimulation is the phosphorylation of tyrosine residue 641 ( 19 ) . BMDMs showed markedly greater sensitivity to IL-4 than to IL-13 in the induction of phosphorylation of Y641 of Stat6, as detected by fl ow cytometry ( Fig. 1 A ,  top) . BMDMs responded to 0.1 ng/ml of IL-4, and 1 ng/ml of IL-4 caused close to maximal Stat6 Y641 phosphorylation, whereas 10 ng/ml of IL-13 was required to obtain detectable phosphorylation and 100 ng/ml to match the phosphorylation induced by 1 ng/ml of IL-4. The relative diff erence of IL-4 -and IL-13 -induced Stat6 Y641 phosphorylation in BMDMs that we measured by intracellular fl ow cytometry was verifi ed by immunoblotting (Fig. S1 , available at http:// www.jem.org/cgi/content/full/jem.20080452/DC1).
To better understand how the type II IL-4 receptor transduces IL-4 signals in BMDMs, we used ␥ c Ϫ / Ϫ mice as a source for these cells because these cells are unable to form type I IL-4 receptor complexes. BMDMs derived from WT or ␥ c Ϫ / Ϫ animals were similar in numbers generated and in phenotype ( 20 ) . Approximately 95% of both WT and ␥ c Ϫ / Ϫ BMDMs were CD11b + and F4/80 + (unpublished data). However, in ␥ c Ϫ / Ϫ BMDMs, Y641 phosphorylation of Stat6 was fi rst detected at 10 ng of IL-4/ml, and there was no greater phosphorylation at 100 or 200 ng/ml ( Fig. 1 A , bottom, and not depicted). IL-13 -induced Stat6 phosphorylation was equivalent in ␥ c Ϫ / Ϫ and WT BMDMs. In ␥ c Ϫ / Ϫ BMDMs, 10 ng/ml of IL-13 induced Stat6 phosphorylation to the same extent as IL-4 at 10 ng/ml, and it exceeded that induced by IL-4 at 100 and 200 ng/ml. The diff erence of Stat6 phosphorylation in response to cytokine stimulation in WT and ␥ c Ϫ / Ϫ cells was quantifi ed by subtracting the median fl uorescence intensity (MFI) of the unstimulated sample from the MFI of the stimulated sample ( Fig. 1 B ) . Fig. 1 B shows results from fi ve independent experiments. Furthermore, DNA-binding of Stat6 as measured by electrophoretic mobility shift assay (EMSA) was virtually absent in ␥ c Ϫ / Ϫ BMDMs stimulated with IL-4 at concentrations ranging from 0.1 to 10 ng/ml, whereas the DNA-binding response to IL-13 at 10 ng/ml was unimpaired in ␥ c Ϫ / Ϫ BMDMs ( Fig. 1 C ) . Defective IL-4 -induced signaling in ␥ c Ϫ / Ϫ BMDMs was not caused by an inability of IL-4 to bind IL-4R ␣ because IL-4 blocked the capacity of anti -IL-4R ␣ to bind to IL-4R ␣ equally in WT and ␥ c Ϫ / Ϫ BMDMs. ( Fig. 1 D ) .
Jak3 is associated with ␥ c, and is critical in mediating signals from the type I, but not the type II, IL-4 receptor ( 21 ). BMDMs were prepared from Jak3 Ϫ / Ϫ mice. As shown in Fig.  1 E , IL-4 -induced Stat6 DNA binding is undetectable in Jak3 Ϫ / Ϫ cells at 10 ng/ml, whereas IL-13 -elicited Stat6 DNA binding is intact in Jak3 Ϫ / Ϫ BMDMs. Thus, these results further emphasize that BMDM responses to IL-4 are highly dependent on the type I receptor. As expected, IFN-␥ has no eff ect on Stat6 DNA-binding activity in either WT or Jak3 Ϫ / Ϫ cells.
Thus, it can be argued that IL-4 acts mainly as a regulatory cytokine and IL-13 largely as an eff ector cytokine.
Macrophages are among the few cell types that express both type I and II receptors. They are involved in both innate and adaptive immune responses by expressing cytokines, by functioning as antigen-presenting cells, and by phagocytosing antigen-bearing entities. M-CSF induces macrophage diff erentiation from BM myeloid stem cells into blood monocytes, and subsequently into tissue macrophages ( 12 ) . In peripheral tissues, tight control of macrophage activation and deactivation is crucial for maintenance of homeostasis. Classical macrophage activation during Th1 responses by IFN-␥ and LPS is well characterized, but recently, macrophage activation by IL-4 and -13 has been studied in detail ( 13, 14 ) . This type II (also termed " alternative " ) macrophage activation by IL-4 and -13 is essential for clearance of Schistosoma mansoni infection because mice lacking IL-4R ␣ expression in macrophages succumb to this helminth ( 15 ) . In the mouse, type II macrophage activation induces expression of genes that are important for granuloma formation ( 16 ) or digesting chitin, which is widely expressed on yeast, arthropods, and nematodes ( 17, 18 ) .
Here, we studied the eff ects of IL-4 and -13 on various monocyte/macrophage populations. We show that BM-derived macrophages (BMDMs), as well as human and mouse monocytes, are far more sensitive to IL-4 than to IL-13. The heightened IL-4 sensitivity of these cell types is totally dependent on the type I IL-4 receptor because the lack of functional ␥ c renders the cells less responsive to IL-4 than to IL-13. Like BMDMs, resident peritoneal macrophages (PMs) from WT mice are more sensitive to IL-4 than to IL-13, but show relatively modest changes in their response to IL-4 in the absence of ␥ c. Thus, these two macrophage cell types, when expressing only the type II receptor, nonetheless diff er in their relative sensitivity to IL-4 and -13. We show that this diff erence can be explained by diff erential expression of IL-13R ␣ 1 between BMDMs and PMs and by the diff erences in affi nity of IL-4 and -13 for the components of their receptors. Among human monocytes, those with an " infl ammatory " precursor phenotype (CD14 hi , CD16 lo ) appear more like peritoneal mouse macrophages, whereas monocytes with a " resident " phenotype (CD14 lo , CD16 hi ) are more similar to BMDMs. Finally, in nonhematopoietic cells, namely fi broblasts and epithelial cells, IL-13 stimulates equal or greater responses than does IL-4. The diff erential responsiveness of these various cell types, based on their diff erential expression of IL-4 -IL-13 receptor chains, helps to explain the distinct function of the two cytokines.
RESULTS

Mouse BMDMs have increased sensitivity to IL-4 over -13
M-CSF -induced in vitro diff erentiation of BM cells is a wellcharacterized and widely used method to obtain large numbers of macrophages. Because BMDMs are not subjected to proinfl ammatory cytokines or Toll-like receptor (TLR) ligands during in vitro diff erentiation, we hypothesized they would represent an immature or naive population of macrophages,
IL-4 -and IL-13 -mediated gene induction in BMDMs
Type II macrophage activation results in induction of several genes, including arginase (Arg) 1. Arg1 plays an important role in regulating macrophage responses, as Arg1 decreases nitric oxide synthase production, and thus nitric oxide, by consuming the substrate, cellular L -arginine ( 22 ) . The promoter of Arg1 contains a Stat6 binding site ( 23 ) , and Arg1 mRNA is induced in mouse macrophages by IL-4 ( 24 ) . As shown in Fig. 2 A , Arg1 mRNA induction at 2 h could be detected in response to 1 ng/ml of IL-4, and peaked at 10 ng/ ml (mean of fold induction, 247). In contrast, IL-13 at < 10 ng/ml did not induce detectable Arg1, and its peak induction (mean of fold induction, 79) was only ‫ف‬ 30% of the levels induced by IL-4 ( Fig. 2 A ) . In ␥ c Ϫ / Ϫ BMDMs, IL-13 induction of Arg1 was comparable to that observed in WT BMDMs, but IL-4 induction of Arg1 was virtually undetectable, even at 100 ng/ml ( Fig. 2 A ) . Anti -IL-4R ␣ (M1) inhibited IL-13-induced Arg1 expression in both WT and ␥ c Ϫ / Ϫ BMDMs, confi rming that IL-13 responses require the IL-4 receptor-␣ chain ( Fig. 2 C ) and that the IL-13 response could not be attributed to a non -IL-4R ␣ -using receptor. The importance of Stat6 in the response to both IL-4 and -13 was demonstrated by the failure of both cytokines to induce Arg1 expression, even at 100 ng/ml in Stat6 Ϫ / Ϫ BMDMs ( Fig. 2 B ) .
IL-4 -and IL-13 -induced responses in PMs and NIH3T3 fi broblasts
We next compared IL-4 -and IL-13 -induced Stat6 phosphorylation in tissue macrophages. We initially examined resident PMs obtained from mouse peritoneal lavages. Typically, these cells were 80 -90% positive for both CD11b and F4/80. These cells were even more sensitive than BMDMs to IL-4. IL-4 -induced Stat6 Y641 phosphorylation was nearly maximal at 0.1 ng/ml ( Fig. 3 A , top) and, at this concentration of IL-4, the P value for the comparison of the degree of Stat6 phosphorylation between BMDMs and PMs, by the unpaired Student ' s t test, was statistically signifi cant (0.014). In contrast to BMDMs, where IL-13 induced no Stat6 phosphorylation at concentrations < 10 ng/ml, IL-13 induced substantial Stat6 phosphorylation in PMs at 1 ng/ml, and was close to the IL-4 maximum at 10 ng/ml. The P value for the comparison of the degree of Stat6 phosphorylation between BMDMs and PMs at 10 ng of IL-13 by unpaired Student ' s t test was statistically signifi cant (0.020). In striking contrast to ␥ c Ϫ / Ϫ BMDMs, PMs from ␥ c Ϫ / Ϫ donors showed only a modest reduction in their sensitivity to IL-4 and were clearly more sensitive to IL-4 than to IL-13 ( Fig. 3 A , bottom). The P values for the comparison of the degree of similar to the data in Fig. 1 B , and represents fi ve experiments for the wild-type cells and three for the ␥ c Ϫ / Ϫ cells. Collectively, IL-4 appears to be an ‫ف‬ 100-fold more potent inducer of Stat6 Y641 phosphorylation than IL-13 in both WT BMDMs and PMs, but a defi ciency of functional type I IL-4 receptors has a fundamentally diff erent impact on IL-4 responsiveness in these two macrophage populations.
In WT PMs, IL-4 -induced Arg1 expression was somewhat greater than that induced by IL-13 ( Fig. 3 C ) . In ␥ c Ϫ / Ϫ PMs, IL-4 -induced Arg1 expression was slightly decreased, but in contrast to ␥ c Ϫ / Ϫ BMDMs, the lack of ␥ c markedly aff ected Arg1 expression only at the lowest cytokine concentration studied (1 ng/ml; Fig. 3 C ) .
The responses to IL-4 and -13 by peritoneal exudate macrophages induced by thioglycollate (Tg) were generally similar to those of resident PMs, although their sensitivity to IL-4 was somewhat less than that of PMs, and they displayed only a minimal response to IL-13 at 1 ng/ml, but quite good responses at 10 ng/ml ( Fig. 3 D ) .
We also compared IL-4 and -13 responses in cells that mainly or exclusively express the type II IL-4 receptor. For this purpose, we tested Stat6 phosphorylation in response to IL-4 and -13 in NIH3T3 fi broblasts. Overnight-starved NIH3T3 cells were stimulated for 15 min with increasing concentrations of IL-4 and -13. At concentrations > 0.1 ng/ml, IL-13 induced Stat6 Y641 phosphorylation substantially better than IL-4 in fibroblasts ( Fig. 3 F ) . In a human lung epithelial cell line (H292), 20 ng/ml of IL-4 and -13 induced comparable tyrosine phosphorylation of immunoprecipitated Stat6 ( 
Mouse monocytes show increased sensitivity to IL-4
Monocytes are macrophage precursors that circulate in blood. They are released into the bloodstream upon diff erentiation of the common myeloid progenitor cells in BM ( 25 ) . Because we hypothesized that BMDMs might represent a relatively immature macrophage pool, we wished to determine whether there are diff erences in IL-4 -and IL-13 -induced signaling in these macrophage precursors that would be similar to the diff erences we detected in BMDMs. Mouse blood monocytes from WT B6 mice were analyzed for responsiveness to IL-4 and -13 by measuring Stat6 Y641 phosphorylation by fl ow cytometry. IL-4 induced substantial responses at 0.1 ng/ml in monocytes, whereas IL-13 required 10 ng/ml to obtain measureable responses ( Fig. 4 A ) . Because of limitations in cell numbers, we did not test responsiveness to 1 ng/ml or 100 ng/ml of either IL-4 or -13. Monocytes from ␥ c Ϫ / Ϫ mice responded poorly to both IL-4 and -13 at 0.1 ng/ml, and slightly better to IL-13 than to IL-4 at 10 ng/ml ( Fig. 4 B ) . Thus, the IL-4 sensitivity of ␥ c Ϫ / Ϫ monocytes resembled that of ␥ c Ϫ / Ϫ BMDMs.
Human monocyte sensitivity to IL-4 over -13 is dependent on ␥ c and occurs in CD14 hi and CD16 hi subtypes Easy accessibility to a large number of monocytes in human peripheral blood and the relatively low number of monocytes in Stat6 phosphorylation between ␥ c Ϫ / Ϫ BMDMs and PMs at concentrations of IL-4 at or > 1 ng/ml are statistically significant (1 ng/ml, 0.003; 10 ng/ml, 0.046; 100 ng/ml, 0.0003). Thus, in PMs, IL-4 effi ciently uses the type II receptor, which it does not in BMDMs, and IL-13 is a relatively better stimulant in PMs than in BMDMs. The data are quantitated in Fig. 3 B , ( Fig. 5 B ) , whereas 0.1 ng/ml of IL-4 induced striking Stat6 DNA binding. These results indicate that human monocytes are also 10 -100-fold more sensitive to IL-4 than to IL-13.
Blocking the type I receptor on human monocytes with ␥ c neutralizing antibody had no inhibitory eff ect on the Stat6 DNA-binding activity induced by IL-13 ( Fig. 5 C ) , but the Stat6 DNA-binding induced by IL-4 was markedly reduced, indicating that type I IL-4 receptors are essential for IL-4 responses in human monocytes, despite the fact that there is suffi cient type II receptor to mediate an IL-13 response.
mice, prompted us to examine the IL-4 -and IL-13 -induced Stat6 activation in human monocytes. IL-4 induced substantial Stat6 Y641 phosphorylation by elutriated human monocytes at concentrations as low as 0.1 ng/ml; maximum Stat6 phosphorylation was obtained at 1 -10 ng/ml of IL-4 ( Fig. 5 A ) . In contrast, IL-13 caused no detectable Stat6 phosphorylation at 0.1 ng/ml and detectable phosphorylation at 1 ng/ml; 10 ng/ml of IL-13 induced close to maximal Stat6 phosphorylation. Consistent with the FACS data, IL-13 failed to induce Stat6 DNA binding at concentrations < 10 ng/ml, as demonstrated by EMSA In that respect, the CD14 hi population resembles the PM population and the CD14 lo resembles the BMDM population. In accord with these diff erences in IL-4 -IL-13 sensitivity between human monocyte populations, we observed that IL-4R ␣ , ␥ c, and IL-13R ␣ 1 are more highly expressed in the CD14 hi populations, and that IL-13R ␣ 2 is barely expressed in either as measured by fl ow cytometry ( Fig. 5 F ) .
Receptor chain expression in BMDMs, PMs, and NIH3T3 fi broblasts Measurements of binding properties of the components of the type I and II receptors and recent structural characterization of type I and II IL-4 receptors ( 28 ) suggested that relative receptor chain expression might provide a mechanism to regulate the relative potency of IL-4 and -13. Indeed, the analysis of receptor chain expression in the human monocyte subpopulations supports this idea ( Fig. 5 F ) . We examined the expression of diff erent receptor chains on BMDMs and PMs by fl ow cytometry, and representative stainings are shown in Fig. 6 A . We quantitated the data from independent stainings in Fig. 6 B . ␥ c expression was detected clearly on both BMDMs and PMs, with fourfold higher expression on PMs. IL-4R ␣ expression was 2.6-fold higher on PMs than on BMDMs ( Fig. 6 B ) .
For mouse IL-13R ␣ 1, no suitable monoclonal antibody is available. We failed to detect a reliable specifi c signal with fl ow cytometry using a polyclonal anti -IL-13R ␣ 1 antiserum. Therefore, we measured IL-13R ␣ 1 expression by immunoblotting. Using antibody against IL-13R ␣ 1, we observed a stronger ‫ف‬ 50-kD band in extracts from PMs than in extracts Human peripheral blood monocytes consist of at least two subpopulations, i.e., CD14 hi /CD16 lo and CD14 lo /CD16 hi , with ‫ف‬ 75% being CD14 hi /CD16 lo . There is still some debate as to the roles of these subpopulations in homeostasis, infections, and infl ammatory responses ( 26, 27 ) , but the CD14 hi / CD16 lo are often considered precursors of infl ammatory macrophages, and the CD14 lo /CD16 hi are considered precursors of resident macrophages. We wished to determine if IL-4 -and IL-13 -induced responses might be diff erent in these monocyte subsets. To exclude contaminating cells, we stained elutriated human peripheral monocyte preparations with anti-CD3, -CD19, and -CD56 to exclude T-, B-, and NK cells. In the CD16 hi -positive gate, we detected very few contaminating cells (CD3, ‫ف‬ 2%; CD19, ‫ف‬ 0%; or CD56, ‫ف‬ 1%), and in the CD14 hi population, there was ‫ف‬ 5% CD56 + and ‫ف‬ 3% CD3 + cells, but no detectable CD19-expressing cells (unpublished data). We examined IL-4 -and IL-13 -induced Stat6 Y641 phosphorylation in these two subsets. Both IL-4 and -13 were able to induce Stat6 activation at lower concentrations in CD14 hi /CD16 lo than in CD14 lo /CD16 hi population ( Fig. 5 D ) . To further confi rm this observation, we compared the IL-4 and -13 responsiveness of four independent donors with similar results ( Fig. 5 E ) .
Collectively, these results confi rm the superiority of IL-4 in inducing Stat6 activation in human monocytes and, further, that this advantage is lost when the type I IL-4 receptor is inhibited. Finally, the CD14 hi monocyte subset is more sensitive to both IL-4 and -13 than the CD16 hi monocyte subpopulation. The diff erence between monocyte populations is particularly clear in the response to IL-13 at 10 ng/ml. from BMDMs; equal loading was confi rmed by Ponceau S staining. By densitometry, PMs expressed 2.5-fold more IL-13R ␣ 1 than did BMDMs ( Fig. 6 C ) . better than to IL-4, despite the fact that both cell types use only the type II receptor?
To rationalize these observations, one needs to take into account the relative expression of the key receptor chains on the various cells and the equilibrium constants that describe the binding events. Based on our fl ow cytometric measurements of receptor chain expression, IL-4R ␣ levels are 2.6-fold higher in PMs than in BMDMs; ␥ c levels are 4 times higher in PMs than BMDMs; and IL-13R ␣ 1 levels are 2.5 times higher in PMs than BMDMs. Neither BMDMs, PMs, nor NIH3T3 have detectable mRNA for IL-13R ␣ 2. Macrophage cell lines have been shown to contain 160 -2,300 IL-4R ␣ , whereas NIH3T3 cells have ‫ف‬ 500 IL-4R ␣ ( 29, 30 ). Human monocytes, which are macrophage precursors and may represent immature macrophage population similar to BMDMs, have been reported to express ‫ف‬ 120 IL-13 binding sites ( 31 ) , which are presumably IL-13R ␣ 1 ( 32 ) . For analysis here, we assumed 1,000 IL-4R ␣ , 1,000 ␥ c, and 200 IL-13R ␣ 1 are expressed by BMDMs. The corresponding levels of expression on PMs would be 2,600, 4,000, and 500, respectively. The equilibrium constants of the binding of the We did not detect IL-13R ␣ 2 mRNA in these cells, and ␥ c mRNA expression was very low (unpublished data). At the protein level, very low levels of ␥ c and IL-4R ␣ expression were detected by fl ow cytometry. By immunoblotting, IL-13R ␣ 1 was more highly expressed in fi broblasts than in BMDMs; IL-13R ␣ 2 was undetectable (Fig. S3 , available at http://www .jem.org/cgi/content/full/jem.20080452/DC1).
Modeling of functional receptor assemblage in response to IL-4 and -13
Our results thus indicate that monocytes and macrophages are exquisitely sensitive to IL-4 and relatively insensitive to IL-13. Furthermore, the IL-4 response of BMDMs and monocytes from ␥ c Ϫ / Ϫ donors is severely impaired, indicating strong dependence on the type I receptor, whereas PMs efficiently respond to IL-4 through the type II receptor. Finally, fi broblasts, relying largely or exclusively on the type II receptor, are more sensitive to IL-13 than to IL-4. How are we to understand these diff erences and, particularly, to explain the capacity of ␥ c Ϫ / Ϫ PMs to respond better to IL-4 than to IL-13 and for ␥ c Ϫ / Ϫ BMDMs to respond to IL-13 equally or complexes can be assembled at a relatively low cytokine concentration and these effi ciently recruit IL-4R ␣ . Responses to IL-4 in PMs are also obtained at lower concentration because of the increased amounts of ␥ c and of IL-13R ␣ 1. Indeed, because of the increase in the amount of IL-13R ␣ 1, the loss of ␥ c has modest eff ect on the IL-4 response.
Maximal responses to IL-4 and -13 are achieved with concentrations of cytokine (100 ng/ml or less) that, according to the model, would form 35 -40 signaling complexes. Concentrations of IL-13 > 100 ng/ml fail to cause greater responses, despite the fact that they would assemble substantially more signaling complexes. However, it is possible that much larger cytokines to their binding chains have been measured, whereas the two-dimensional equilibrium constants of the binding of membrane-associated cytokine/binding chain complex to ␥ c, IL-13R ␣ 1, or IL-4R ␣ remain as free parameters, but may be estimated from the data available for similar membrane receptors ( 33 ) and from the measured solution binding constants ( 28 ) .
For ( 33 ) .
The implications of the relative numbers of receptors and the equilibrium constants are as follows. IL-4 binds with high affi nity to IL-4R ␣ . Thus, IL-4 saturates its binding chain at relatively low cytokine concentration. However, the IL-4 -IL-4R ␣ complex binds with low affi nity to either ␥ c or IL-13R ␣ 1. This eff ectively means that the number of signaling receptors formed (i.e., the ligand -ligand receptor -second chain complex) in response to IL-4 will be highly sensitive to the numbers of ␥ c or IL-13R ␣ 1 chains. However, raising IL-4 concentrations will have very little eff ect. For IL-13, the situation is fundamentally diff erent. IL-13 binds its ligand-binding chain with low affi nity, and therefore the saturation of binding chains is not achieved at low concentrations of cytokine. Thus, the amount of bound IL-13 increases as the cytokine concentration increases. However, the cytokine -binding chain complex binds to IL-4R ␣ with high effi ciency so that the proportion of bound ligand -binding chains that are assembled into signaling chains is high, and the number of signaling chains continues to rise as ligand concentration increases, until most IL-4R ␣ chains are bound.
Based on our data and the aforementioned binding constants, we wrote a Matlab script to predict the receptor chain assemblage (for details see Materials and methods). For BMDMs ( Fig. 7 A ) , where there are substantial numbers of IL-4R ␣ chains and of ␥ c chains, but limiting amounts of IL-13R ␣ 1, the prediction is that IL-4 responses are good because large numbers of IL-4 -IL-4R ␣ complexes are formed and there is suffi cient ␥ c to drive a reasonable proportion of these into signaling chains. When ␥ c is not present, the concentration of IL-13R ␣ 1 is so low that the number of signaling complexes formed is greatly reduced. In addition, the number of signaling complexes formed is substantially less than the number of IL-13R ␣ 1 chains present because they are recruited to the IL-4 -IL-4R ␣ complex relatively ineffi ciently. However, the number of signaling chains that can be formed in response to IL-13 can approach the number of IL-13R ␣ 1 chains if suffi cient IL-13 is used because the recruitment of IL-4R ␣ to the IL-13 -IL-13R ␣ 1 complex is effi cient. Thus, the ␥ c Ϫ / Ϫ cells respond poorly to IL-4, but can respond quite well to relatively high concentrations of IL-13.
In PMs ( Fig. 7 B ) , IL-13R ␣ 1 levels are 2.5-fold higher than in BMDMs. This results in a greater sensitivity of the cells to IL-13 because adequate numbers of IL-13 -IL-13R ␣ 1 IL-4 is reported to be superior to IL-13 in its ability to activate IRS-2 in a ␥ c-dependent manner at IL-4 and -13 concentrations that induce full Stat6 activation (unpublished data).
As we were fi nalizing this study, it was shown, using PMs and BMDMs from IL-13R ␣ 1 Ϫ / Ϫ mice, that alternative macrophage activation in vivo does not absolutely require IL-13 ( 8 ) . In line with these fi ndings, we show that Arg1 expression is up-regulated more strongly by IL-4 than by IL-13 in WT BMDMs. Furthermore, we observed a pattern of enhanced IL-4 and -13 responsiveness in PMs. Taking into account the diff erent cell types used here, comparison of IL-4 and -13 responses revealed that relatively immature macrophages (monocytes and BMDMs) rely heavily on the type I receptor; this leads to their relative insensitivity to IL-13. More mature tissue macrophages (PMs) are still extremely sensitive to IL-4, but the lack of type I receptor expression has only a modest eff ect on IL-4 responses. This suggests that PMs have an additional mechanism to maintain IL-4 signaling that the BMDMs do not. It was obvious that the degree of IL-13R ␣ 1 expression could explain this diff erence. Indeed, IL-13R ␣ 1 expression was elevated in PMs.
Human monocytes consist of at least two subpopulations, namely CD14 hi /CD16 lo and CD14 lo /CD16 hi cells. Although there is still controversy regarding the functional properties of these cells, based on the ability to transmigrate through normal endothelium, CD14 hi /CD16 lo cells are believed to be infl ammatory, whereas CD14 lo /CD16 hi cells are " residential " monocytes, feeding into the residential pool of macrophages ( 26 ) . The sensitivity of CD14 hi /CD16 lo cells toward both IL-4 and -13 was elevated compared with CD14 lo /CD16 hi cells. In fact, the phosphorylation patterns of Y641 of Stat6 were strikingly similar between mouse BMDMs and human CD14 lo /CD16 hi monocytes, whereas mouse PMs and human CD14 hi /CD16 lo monocytes resembled each other. Despite our observation that blocking ␥ c rendered human monocytes from apparently healthy donors unresponsive to IL-4, it is of note that monocytes from a severe combined immunodefi ciency disease (SCID) patient with dysfunctional Jak3 kinase responded to IL-4 and -13 with relatively similar potency ( 38 ) . Therefore, it would be of great interest to study in detail the level of IL-13R ␣ 1 expression in monocytes from this patient because this patient might have elevated expression of IL-13R ␣ 1 to compensate for dysfunctional type I IL-4R signaling, which may explain the discrepancy with our fi ndings.
Because IL-13R ␣ 1 -defi cient mice show exacerbated Th2 responses during parasite infections, it has been suggested that the type II IL-4 receptor plays an inhibitory role in Th2 responses in vivo ( 8 ) . However, it can also be argued that the inability of IL-13R ␣ 1 Ϫ / Ϫ mice to expel Nippostrongylus brasiliensis parasites subject the mice to a more prolonged antigenic stimulus, thus enhancing the Th2 response, similar to what is observed in IL-13 -defi cient mice that are also incapable of expelling the parasite despite a robust Th2-cytokine response ( 39 ) .
IL-13R ␣ 2 has been proposed to be a decoy receptor for IL-13; it binds IL-13 with high affi nity ( 40 ) . Despite persistent eff orts, we did not detect any IL-13R ␣ 2 RNA expression in increases in cytokine concentration might lead to increased responses, possibly by recruiting new signaling intermediates.
The model indicates that in BMDMs, 15 signaling complexes are formed in response to 0.1 -1 ng/ml IL-4 and to ‫ف‬ 100 ng/ml IL-13, but no concentration of IL-4 achieves 15 signaling complexes in ␥ c Ϫ / Ϫ cells. In contrast, in PMs, > 15 signaling complexes are formed in response to 0.1 ng/ml IL-4 and to slightly more than 10 ng/ml of IL-13. Deleting ␥ c increases the required concentration of IL-4 to form 15 signaling complexes ‫ف‬ 10-fold, but 1 ng/ml is still suffi cient to achieve this number.
Finally, in fi broblasts ( Fig. 7 C ) , at cytokine concentrations of > 10 ng/ml, IL-13 displays a superior capacity to assemble functional receptor complexes. For fi broblast analysis, we used values for the expression of IL-4R ␣ (500/cell) and IL-13R ␣ 1 (1,000/cell), based on the literature ( 30, 36 ) .
DISCUSSION
The role of the Th2 cytokines IL-4 and -13 during parasite infections and allergic infl ammatory conditions is well established ( 3, 37 ) . Although most results suggest that IL-4 plays its major role in determining the character of the immune response that will occur, and IL-13 is the major mediator of allergic infl ammation, relatively little is known about the comparative potencies of these cytokines on various cell types.
The recently published crystal structures of IL-4 -IL-4R ␣ with ␥ c and with IL-13R ␣ 1, and of IL-13 -IL-13R ␣ 1 with IL-4R ␣ , provides valuable information about these interactions ( 28 ) . The unique top-mounted, Ig-like domain in the extracellular portion of IL-13R ␣ 1 appears to play an important role in dictating the effi ciency of the binding of the IL-13 -IL-13R ␣ 1 binary complex to IL-4R ␣ and the relatively weak binding of the IL-4 -IL-4R ␣ binary complex to IL-13R ␣ 1. The former binding event has a solution K A of 0.5 × 10 8 M Ϫ1 and the latter a K A 2.10 6 M Ϫ1 , indicating that the exact same receptor chains, assembled in reversed order by diff erent " driver " cytokines, behave very diff erently. This thermodynamic data, together with previous solution measurements of the binding affi nities, form the basis of our model to explain how IL-4 and -13 can bind to cells with the same receptors in such a manner that the relative abundance of the two receptors determines the relative sensitivity to these two cytokines.
The type II IL-4 receptor is ubiquitously expressed, whereas the type I IL-4 receptor is mainly restricted to hematopoietic cells. Because mouse lymphocytes do not express IL-13R ␣ 1, macrophages are among the few cell types expressing both type I and II IL-4 receptors that off er an easily accessible model to study IL-4 -and IL-13 -induced signaling via both types of IL-4 receptors. Furthermore, as lack of ␥ c does not interfere with macrophage development ( 20 ) , the role of the type I IL-4 receptor in diff erent macrophage populations is easy to address. We also tested responses of mouse fi broblasts and human airway epithelial cells, two nonhematopoietic cell types that are thought to express only type II receptors. We limited ourselves to studying the eff ect of IL-4 and -13 on Stat6 activation and Stat6-mediated gene expression. However, it is of interest to note that In contrast to the tuning mechanism used to control relative sensitivity in the IL-4 -IL-13 system when only IL-4R ␣ and IL-13R ␣ 1 are available, other cytokine systems with a common signaling mechanism regulate their sensitivity to distinct ligands by controlling the expression of a key binding chain. In the IL-3 cytokine family, the expression of specifi c ␣ -chain (IL-3R ␣ -, IL-5R ␣ -, or GM-CSFR ␣ -chain) triggers heterodimerization to a common ␤ -chain, which initiates signaling. Thus, myeloid cells regulate their responsiveness to these cytokines by controlling expression of the ␣ -chains ( 44 ) . In the case of IL-2 and -15, which both use the IL-2R ␤ -IL-2R ␥ complex, specifi city depends on the expression of IL-2R ␣ or IL-15R ␣ ( 45 ), and for IL-7 and TSLP, which share the IL-7R ␣ chain, specifi city depends on the relative expression of ␥ c and TSLPR ( 46 ) . In this respect, the IL-4 -IL-13 system displays a novel mechanism to tune the responsiveness of different cell types to these two cytokines that are structurally analogous, but functionally quite distinct.
Collectively, these observations and the results presented here are consistent with the following scenario. During Th2 responses, early low-concentration IL-4 production can elicit eff ective Th2-type monocyte responses. As infl ammation persists, IL-13 production increases, and the concentration of IL-13 in serum become such that it can also induce effi cient responses by both hematopoietic and nonhematopoietic cells. The high degree of toxicity of IL-4 compared with IL-13 may explain why IL-4 concentrations are held at low levels, whereas IL-13 can be produced in larger amounts. IL-13 ' s equal or greater stimulatory capacity for nonhematopoietic cells makes it the dominant eff ector cytokine.
MATERIALS AND METHODS
Mice and cell cultures. Wild type, ␥ c Ϫ / Ϫ , and Stat6 Ϫ / Ϫ C57BL/6J mice were obtained from The Jackson Laboratory. Jak3 Ϫ / Ϫ mice ( 47 ) were provided by J. O ' Shea (National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD). Mice were maintained in the National Institute of Allergy and Infectious Diseases specifi c pathogen -free animal facility, and the experiments were done under an approved protocol according to the National Institute of Allergy and Infectious Diseases guidelines for animal care. For obtaining BMDMs and PMs, previously described methods were used ( 48 ) . BMDMs were diff erentiated in eMEM media containing 10% FBS, penicillin/streptomycin, 2 mM L -glutamine, 0.02% sodium bicarbonate, and 30 ng/ml M-CSF (R & D Systems). Typically, > 95% of cells in BMDM cultures were positive for CD11b and F4/80 surface markers after 8-10 d. Before stimulating the BMDMs with cytokines, the cells were starved in growth media containing 2% FBS without M-CSF. After fl ushing of the peritoneal cavities, PMs were cultured overnight in RPMI containing 2% fetal bovine serum, glutamine, 10 mM Hepes, penicillin/streptomycin, 50 μ M 2-mercaptoethanol, and nonessential amino acids. In a typical experiment, cultured cells were 80 -90% positive for CD11b and F4/80. Both BMDMs and PMs were cultured on non -tissue culture -treated plates to alleviate the mechanical detachment of the cells from the plates. NIH3T3 and H292 cells were obtained from American Type Culture Collection and were grown in the same media as PMs with 10% FBS. Elutriated human monocytes were obtained from NIH Blood Bank; they were cultured in RPMI containing 2% FBS for 2 h before stimulation with human IL-4 (R & D Systems and Peprotech) or human IL-13 (R & D Systems and Peprotech). All cells were maintained at 37 ° C with 5% CO 2 .
Antibodies. For Western blotting, anti-pStat6 and -Stat6 antibodies obtained from Cell Signaling Technology and Epitomics were used. For mice, BMDMs, PMs, or NIH3T3 cells (unpublished data), indicating that the observed diff erences in the strength of IL-13 -induced signaling in BMDMs versus PMs is not caused by expression of an inhibitory IL-13 receptor.
In NIH3T3 fi broblasts, IL-13 was superior to IL-4 in inducing Stat6 phosphorylation. IL-4 and -13 induced comparable degrees of Stat6 phosphorylation in a human lung epithelial cell-line (H292). Together with the observations that larger amounts of IL-13 than -4 are produced in Th2 responses, the relative abundance of IL-4R ␣ and -13R ␣ 1 explains the central role played by IL-13 rather than IL-4 in mediating eff ector functions by nonhematopoietic cells ( 9 -11 ) .
We have presented a model that accounts for the diff erences in potency in these various cell types based on the relative expression of the three receptor chains and on the relative affi nities of these chains for their ligands. The basic diff erences in the " logic " of responses to IL-4 and -13 is that IL-4 binds to IL-4R ␣ with very high affi nity, allowing it to capture cytokines at a very low concentration. However, the construction of the signaling complex is relatively ineffi cient because the affi nity of the IL-4 -IL-4R ␣ complex for either ␥ c or IL-13R ␣ 1 is quite low, so when these chains are limiting, IL-4 responses are severely blunted. In contrast, IL-13R ␣ 1 binds IL-13 with low effi ciency. High concentrations of IL-13 are required to assemble the IL-13 -IL-13R ␣ 1 complex, but the subsequent step, the binding of IL-4R ␣ , is relatively effi cient so that one can assemble large numbers of signaling complexes if one uses suffi ciently large amounts of IL-13. It should be pointed out that other, more complex, models are possible, particularly if multimers of the signaling complex form and if these forms have distinctive signaling capabilities.
What might be the reason for having two functionally overlapping cytokine receptors? As noted, IL-4 is essential for immunoglobulin class switching and for Th2 diff erentiation. This is easily explained because, in the mouse, IL-13R ␣ 1 is not expressed on lymphocytes, and thus such cells cannot bind IL-13. In contrast, IL-13 is the key eff ector cytokine. Blocking of IL-13, but not IL-4, can inhibit airway hypersensitivity responses in mice ( 9 -11 ). IL-13, but not IL-4, is essential for expulsion of parasites in N. brasiliensis infection ( 8, 39 ) . These fi ndings can be explained both by the equal or greater potency of IL-13 on nonhematopoietic cells and the larger amounts of IL-13 produced in allergic infl ammatory responses that may be sustained (or produced) longer than IL-4 at the site of the infl ammation ( 41 ) . Serum IL-13 concentrations during allergic infl ammatory responses are often detectable, whereas IL-4 can rarely be found in measurable amounts. For example, in a comparison of atopic patients ' PBMC responses to mite allergen, the level of IL-13 was ‫ف‬ 28 times higher than IL-4 in cell culture supernatant ( 42 ) . In another study, PBMCs from healthy donors that were stimulated for 48 h with anti-CD3 mAb expressed ‫ف‬ 10-fold more IL-13 than -4, as measured by ELISA from supernatants ( 43 ) . It is also interesting that short-term administration (3 d) of IL-4 to B6 mice results in far greater toxicity than does the same or even larger amounts of IL-13 (unpublished data). Electrophoretic mobility shift assay. Nuclear protein extracts were prepared from cytokine-treated cells using a modifi cation ( 50 ) of the original method ( 51 ) . A double-stranded oligonucleotide probe (SBE1) based on a DNA sequence present in the promoter of the human IL-1ra gene was used as a probe in the gel-shift assays ( 52 ) . This oligonucleotide contains an N4-type GAS element that preferentially binds Stat6, but not Stat1. Binding reactions were performed as previously described ( 53 ) . A portion of each binding reaction mixture (8 μ l per sample) was electrophoresed on nondenaturing, 6% polyacrylamide gels (Invitrogen) using 0.25x Tris-borate-ethylenediamine-N , N , N Ј , N Ј -tetraacetic acid buff er (22 mM Tris-HCl, pH 8.0, 22 mM borate, and 0.5 mM ethylenediamine-N , N , N Ј , N Ј -tetraacetic acid). The gels were subsequently dried and visualized by autoradiography.
Western blotting. 2 × 10 5 BMDM or PM cells were lysed in Triton lysis buff er. 150 μ g of the total cell lysate from BMDMs and PMs were separated on 12% PAGE-gel, followed by Western blotting and probing of the fi lter with IL-13R ␣ 1 antibody (Santa Crutz Biotechnology). Detection was performed using SuperSignal West Dura Extended Duration Substrate-kit (Thermo Fisher Scientifi c) according to the manufacturer ' s instructions, and equal loading was confi rmed either with Ponceau S staining or by reprobing the fi lter with antibody against actin.
Flow cytometry. Cell surface markers were stained with the aforementioned antibodies after washing with FACS buff er (1X PBS, 0.1% BSA). For pStat6 intracellular stainings, cells were fi xed with 4% paraformaldehyde, and permeabilized with ice-cold 90% methanol followed by staining for 30 min at RT, after which cells were washed and analyzed with FACSCalibur.
For each diff erent cell type, the specifi city of pStat6 antibody was verifi ed by using unspecifi c isotype control. No shift compared with unstimulated cells was detected upon IL-4 or -13 stimulation at 100 ng/ml with isotype control in any cell type.
Statistical analysis.
All error bars on graphs show ± the SEM, except in Fig. 3 B , where only + SEM is shown to make the fi gure more easy to read.
All P values were calculated using unpaired Student ' s t test.
Mathematical modeling. We used Matlab to calculate the fraction of receptors (IL-4R ␣ ) bound to both cytokine (IL-4 or IL-13) and the second receptor chain ( ␥ c or IL-13R ␣ 1 for IL-4 binding and only IL-13R ␣ 1 for IL-13 binding, respectively) as a function of cytokine concentration. Detailed script is provided in Fig. S4 (available at http://www.jem.org/cgi/
